The Radiant Creations Group (Radiant) (Trading Symbol-RCGP) develops and markets unique and proprietary scientific technologies, as well as cosmetic and over-the-counter products for personal enhancement. These products combine new technologies with herbal extracts from centuries of Traditional Chinese Medicine. Dr. Yin-Xiong Li, M.D. Ph.D. is a world-renowned geneticist and a Chief Medical Officer in China. He is also the chief scientific advisor to Radiant. Radiant acquired an exclusive license agreement for Dr. Li’s patented, patent pending  and trade secret technologies that includes “Enhanced Broad-Spectrum UV Radiation Filters and Methods” which is an improvement application for DNA protection from UV radiation.


The comprehensive asset acquisition includes several skin cosmetics products including Revivasol and Revivasol SPF 15. Radiant brings an innovative approach to anti-aging technology with the introduction of Revivasol Anti-Aging and Moisturizing

Creme. Revivasol seeks to create an environment in which the body’s natural healing mechanisms can thrive with less burden. Revivasol is the result of a worldwide search for exotic ingredient systems with proven anti-aging ingredients including AcetylOctapeptide Snap-8. When these ingredients were formulated into Revivasol the combination produced accelerated and noticeable results. The skin is softer, age spots and wrinkles are reduced or eliminated in an environment where the body can naturally heal. Revivasol also features an exotic timed release hydration system which forms a collagen based layer on the surface of the skin. The layer lasts up to 8 hours and by osmosis a natural hydration ingredient is evenly and near perfectly time released to assist in off-loading the body’s need to repair dried and undernourished skin cells. This unique delivery system system is natural and houses all the combinational ingredients selected by Dr. Li.


Radiant also has other innovative technologies in development through our exclusively patent and patent pending licensed by Dr. Li. These technologies include skin protection from the sun, UV radiation from tanning beds, industrial UV sources (such as

welding), and reducing collateral damage from medical radiation treatment.

Currently available for purchase is our Anti-Aging & Moisturizing Crème. In production we have our Anti-Aging & Moisturizing Crème with SPF 15 and a sun block with SPF 30. Future cosmetic products include an over-the-counter acne treatment, a deep wrinkle crème, and a nucleotide protection crème to guard against DNA damage.


Radiants nucleotide protection creme uses a unique technology developed and included in Radiant’s exclusive licensed patent in addition to the existing delivery system in Revivasol. This technology strips out the four nucleotide code molecules from DNA strands and uses them in a system that can provide up to 99% protection from DNA damage caused by high energy UV light, which is the major cause of aging and skin cancer. The harmful effects of sunburn are well known, but exposure to the UV radiation in sunlight does more than just damage the surface of the skin. DNA damage, such as free radicals, oxidative stress, and mutational changes can lead to cancer and other serious conditions.


Another exciting product line currently under development that is cutting edge for the dietary supplement market is our BioSalts. BioSalts have been formulated with an exclusive combination of natural Chinese herbal ingredients to assist the body in a number of ways. Fat burning, weight loss, weight control, increased energy, enhanced sleep, tissue regeneration, lower blood pressure, and regulation of energy homeostasis are all benefits that one can expect from using our BioSalts products. As a supplement, it also promotes liver health.


Within Radiant lies a un-consolidated wholly owned subsidiary named NIT Enterprises Inc. (NITE). NITE was formed to further develop other specific applications that can be derived from the exclusively licensed patent and patent pending. NITE plans to explore the use of Nucleotides is areas such as protection from ionizing radiation, CBRN, bio-threat protection, industrial paint additives, hospital and medical applications and chemical protection for first responders. Additional information regarding these applications can be found in the NIT Enterprises Executive Summary available upon request and on the website at:



Gary R.
President, CEO &
Chairman of the Board Manpreet
SINGH Director and COO Gary D.
Director, CFO, Executive
VP & Corporate Secretary Michael S.
VP of Finance,
Sales & Marketing Anthony A.
Senior VP of New
Product Development

Submitting Form...

The server encountered an error.

Form received.